Tenderwize
Back to tender search

Raamovereenkomst voor de aankoop van Infliximab voor intraveneuze toediening

Ziekenhuis aan de Stroom vzw (ZAS)·Antwerpen, Belgium·EUR 2.3M·Deadline Jul 01, 2026 · 7 days left·Open·Supplies·Framework
Sign up to saveOpen documentsTED notice
High valueStructured notice only
55/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

55 / 100

Complexity

30 / 100

Risk factors

Maximum of 3 contractors awarded, so even if qualified, many bidders may be excluded at the final selection stage.

All documents must be in Dutch; non-Dutch bidders may need translation services, increasing cost and risk of errors.

Submission deadline in 7 days

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • EUR 2.3M estimated value
  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration 12 MONTH
  • Supply of Infliximab for intravenous administration under a framework agreement.
  • Duration: 12 months, with possible entry into force on 2026-09-01.
Show full summary

This is an open tender for a 12-month framework agreement for the supply of Infliximab for intravenous administration, issued by Ziekenhuis aan de Stroom vzw (ZAS), a hospital in Antwerp, Belgium. The contract value is estimated at EUR 2,300,000 with a framework maximum of EUR 3,320,000. Submission deadline is 2026-07-01 10:00 (CEST). The tender is in Dutch, electronic submission is required, and award is based on quality (40%) and price (60%). Only one lot is identified in the notice, despite structured data indicating multiple lots.

Risks

Maximum of 3 contractors awarded, so even if qualified, many bidders may be excluded at the final selection stage.

All documents must be in Dutch; non-Dutch bidders may need translation services, increasing cost and risk of errors.

Submission deadline in 7 days

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Administrative

  • Tenders must be submitted electronically via Open portal
  • Language of tender: Dutch (NLD).
  • Submission deadline: 2026-07-01 10:00 (CEST).

Requirements may be incomplete.

Award Criteria

Lot 1

Kwaliteit — 30%

Buyer

Name

Ziekenhuis aan de Stroom vzw (ZAS)

Location

Antwerpen, BEL

Website

www.zas.be

Identifier

0862382656

Lots (1)

LOT-0001

Raamovereenkomst voor de aankoop van Infliximab voor intraveneuze toediening

Framework agreement for the purchase of Infliximab for intravenous administration. Supply contract with a duration of 12 months, renewable? Not specified. Maximum of 3 operators may be awarded.

SuppliesFrameworkEU fundedElectronic submission

EUR 2.3M

Estimated value

Location

Belgium

Duration

Aug 2026

Category

Antineoplastic and immunomodulating agents

Selection criteria

Quality

Deadline

Deadline Jul 01, 2026

Procurement Details

Publication date
28 May 2026
Notice type
Contract notice — standard
Languages
Dutch

Reference metadata

Notice subtype
16
Notice version
1
Legal basis
32014L0024

Reference IDs

Tender ID
368381-2026
Source notice ID
e4ab2ff8-5168-4867-a1a4-8f980e0f93a9

Documents (1)

Procurement document 1

Similar tenders

Poland – Antineoplastic agents – Dostawa produktów leczniczych i wyrobów medycznych do Wojskowego Instytutu Medycznego – PIB

POLJul 23

Romania – Antineoplastic agents – achizitia de medicamente utilizate in tratamentul pacientilor beneficiari ai Programului Programului national de oncologie-Subprogramul de tratament medicamentos al bolnavilor cu afectiuni oncologice (adulti si copii), Programul national de oncologie medicamente COST-VOLUM

ROUJul 27

Poland – Immunoglobulins – Dostawy produktów leczniczych, wyrobów medycznych oraz substancji do receptury

POLJul 6

Poland – Medicinal products for the blood, blood-forming organs and the cardiovascular system – Dostawa produktów leczniczych dla krwi, organów krwiotwórczych oraz układu krążenia, toksyn, środków leczniczych dla układu oddechowego, środków przeciwnowotworowych i immunomodulacyjnych stosowanych w ramach programów lekowych i chemioterapii, immunoglobulin oraz środków antywirusowych do użytku ogólnoustrojowego dla SPWSZ w Szczecinie

POLJun 26

Slovakia – Antineoplastic and immunomodulating agents – Antineoplastické a imunomodulačné činidlá ( bežné )

SVKJul 13

Poland – Antineoplastic and immunomodulating agents – DOSTAWA LEKÓW ONKOLOGICZNYCH DLA WOJEWÓDZKIEGO SZPITALA SPECJALISTYCZNEGO IM. NAJŚWIĘTSZEJ MARYI PANNY W CZĘSTOCHOWIE

POLJul 17